OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Non-household contact;Other;Sex
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Singapore
Location: Tan Tock Seng Hospital, Singapore
Study period:  Apr-04 2003 to  Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Singapore
Location: Tan Tock Seng Hospital, Singapore
Study period:  Apr-04 2003 to  Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 57
Unit: Percentage (%)
Value type: Unspecified
Epidemic phase: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 19
Maximum age: 64
Sample size: 80
Country: Singapore
Location: Tan Tock Seng Hospital, Singapore
Study period:  Apr-04 2003 to  Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 56
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 45
CFR/IFR denominator: 80
Epidemic phase: Unspecified
Disaggregated by: Symptoms
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 19
Maximum age: 64
Sample size: 80
Country: Singapore
Location: Tan Tock Seng Hospital, Singapore
Study period:  Apr-04 2003 to  Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 15
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 10
Upper bound: 17
Bounds: 10 - 17
CFR/IFR numerator: 17
CFR/IFR denominator: 111
CFR/IFR method: Naive
Epidemic phase: Unspecified
Disaggregated by: Age, Occupation, Other, Sex
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 16
Maximum age: 82
Sample size: 111
Country: China
Location: Pingjin Hospital, Tianjin, China
Study period:   2003 to 6  2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 82
Country: China
Location: Pingjin Hospital, Tianjin, China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Cormobidity;Occupation;Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 82
Country: China
Location: Pingjin Hospital, Tianjin, China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Cormobidity;Occupation;Other;Sex
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 16
Maximum age: 77
Sample size: 90
Country: China
Location: Pingjin Hospital, Tianjin, China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 16
Maximum age: 77
Sample size: 90
Country: China
Location: Pingjin Hospital, Tianjin, China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0.079
Upper bound: 3.333
Bounds: 0.079 - 3.333
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 33
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Parameter value: 0.636
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 188
CFR/IFR denominator: 29751
Epidemic phase: Unspecified
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 33
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Parameter value: 0.121
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 36
CFR/IFR denominator: 29751
Epidemic phase: Unspecified
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 33
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Unit: No units
Value type: Unspecified
Lower bound: 2.21
Upper bound: 2.53
Bounds: 2.21 - 2.53
Epidemic phase: Unspecified
Reproduction number method: Compartmental model
Reproduction number pathway: Unspecified
Disaggregated by: Time
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 11 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 1.88
Unit: No units
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 1.85
Uncertainty upper value: 1.91
Combined uncertainty: 1.85 - 1.91 (95% CI)
Epidemic phase: Unspecified
Reproduction number method: Compartmental model
Reproduction number pathway: Unspecified
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Taiwan,  China
Study period: 25 Feb-02 2003 to 25 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Lower bound: 1.0698
Upper bound: 3.2524
Bounds: 1.0698 - 3.2524
Epidemic phase: Unspecified
Reproduction number method: Compartmental model
Reproduction number pathway: Unspecified
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 27 Apr-04 2003 to 10 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 9.7
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 2.5
Upper bound: 47.7
Bounds: 2.5 - 47.7
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Mixed groups
Sample type: Hospital based
Sex: Unspecified
Sample size: 1140
Country: China
Location: Pingjin Hospital, Tianjin
Study period: 16 Apr-04 2003 to 12 May-05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - latent period
Parameter value: 4
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 11
Combined uncertainty: 2 - 11 (Range)
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Unspecified
Minimum age: 16
Maximum age: 82
Sample size: 111
Country: China
Location: Pingjin Hospital, Tianjin
Study period: 16 Apr-04 2003 to 12 May-05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 11.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 13
CFR/IFR denominator: 111
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 16
Maximum age: 82
Sample size: 111
Country: China
Location: Pingjin Hospital, Tianjin
Study period: 16 Apr-04 2003 to 12 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 8378
Country: Singapore
Study period: 13 Mar-03 2003 to 31 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 1018
Country: Singapore
Study period: 13 Mar-03 2003 to 31 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Close contact;Cormobidity;Occupation;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 86
Country: Singapore
Location: Communicable Disease Centre in Tan Tock Seng Hospital, Singapore
Study period: 1 Mar-03 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other;Sex
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 86
Country: Singapore
Location: Communicable Disease Centre in Tan Tock Seng Hospital, Singapore
Study period: 1 Mar-03 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 86
Country: Singapore
Location: Communicable Disease Centre in Tan Tock Seng Hospital, Singapore
Study period: 1 Mar-03 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 86
Country: Singapore
Location: Communicable Disease Centre in Tan Tock Seng Hospital, Singapore
Study period: 1 Mar-03 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 10
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 12.5
Bounds: 0 - 12.5
Epidemic phase: Post outbreak
Disaggregated by: Other
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 90
Sample size: 70
Country: Singapore
Location: Singapore General Hospital
Study period: 5 Apr-04 2023 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 14
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 1
CFR/IFR denominator: 7
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 37
Maximum age: 74
Sample size: 7
Country: Singapore
Location: Singapore General Hospital
Study period: 5 Apr-04 2023 to
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.09
Unit: Days
Value type: Mean
Uncertainty type: Range
Uncertainty lower value: 0
Uncertainty upper value: 14
Uncertainty single value: 9.65 (Variance)
Combined uncertainty: 0 - 14 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 16
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Disaggregated by: Occupation, Other, Time
Risk factor: Hospitalisation;Household contact;Non-household contact;Other;Social gathering
Risk factor outcome: Infection
Risk factor occupation: Healthcare;Unspecified
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Unspecified
Sample type: Hospital based
Sex: Unspecified
Minimum age: 0.4
Maximum age: 99
Sample size: 225
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Disaggregated by: Occupation, Other, Time
Risk factor: Hospitalisation;Household contact;Non-household contact;Other;Social gathering
Risk factor outcome: Infection
Risk factor occupation: Healthcare;Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Unspecified
Population group: Unspecified
Sample type: Hospital based
Sex: Unspecified
Minimum age: 0.4
Maximum age: 99
Sample size: 225
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 1
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 0.8
Uncertainty upper value: 1.1
Combined uncertainty: 0.8 - 1.1 (95% CI)
Epidemic phase: Unspecified
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 23103
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 96.1
Unit: Percentage (%)
CFR/IFR numerator: 124
CFR/IFR denominator: 129
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 129
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 3.9
Unit: Days
Value type: Mean
Uncertainty single value: 3.2 (Standard Deviation)
Combined uncertainty: 3.2 (Standard Deviation)
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Unspecified
Minimum age: 0
Maximum age: 99
Sample size: 225
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Other delay start: Symptom Onset/Fever
Other delay end: Reporting
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.7
Unit: Days
Value type: Mean
Uncertainty type: Range
Uncertainty lower value: 1
Uncertainty upper value: 12
Combined uncertainty: 1 - 12 (Range)
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 59
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 16.9
Unit: Percentage (%)
CFR/IFR numerator: 38
CFR/IFR denominator: 225
CFR/IFR method: Naive
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Population based
Sex: Unspecified
Minimum age: 0
Maximum age: 99
Sample size: 225
Country: Canada
Location: Toronto
Study period: 23 Feb-02 2003 to 1 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 98.41
Unit: Percentage (%)
CFR/IFR numerator: 124
CFR/IFR denominator: 126
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 126
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital, Shatin, NT
Study period: 11 Mar-03 2003 to 25 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Other;Sex
Risk factor outcome: Other
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 138
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital, Shatin, NT
Study period: 11 Mar-03 2003 to 25 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Other
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 138
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital, Shatin, NT
Study period: 11 Mar-03 2003 to 25 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 0
Uncertainty upper value: 11
Combined uncertainty: 0 - 11 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 138
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital, Shatin, NT
Study period: 11 Mar-03 2003 to 25 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 10.9
Unit: Percentage (%)
CFR/IFR numerator: 15
CFR/IFR denominator: 138
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 138
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital, Shatin, NT
Study period: 11 Mar-03 2003 to 28 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Parameter value: 4.2
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 1.5
Uncertainty upper value: 7
Combined uncertainty: 1.5 - 7 (95% CI)
Epidemic phase: Mid outbreak
Population group: Mixed groups
Sample type: Contact based
Sex: Both
Minimum age: 0
Maximum age: 82
Sample size: 212
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 6.7
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 0.6
Uncertainty upper value: 14
Combined uncertainty: 0.6 - 14 (95% CI)
Epidemic phase: Mid outbreak
Population group: Mixed groups
Sample type: Contact based
Sex: Both
Minimum age: 0
Maximum age: 82
Sample size: 212
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Close contact;Cormobidity;Household contact;Non-household contact;Other;Sex
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Contact based
Sex: Both
Minimum age: 0
Maximum age: 82
Sample size: 212
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Household contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Mixed groups
Sample type: Contact based
Sex: Both
Minimum age: 0
Maximum age: 82
Sample size: 212
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 0.2
Unit: No units
Value type: Other
Epidemic phase: Mid outbreak
Reproduction number method: Empirical (contact tracing)
Reproduction number pathway: Human-human
Population group: Mixed groups
Sample type: Contact based
Sex: Both
Minimum age: 0
Maximum age: 82
Sample size: 212
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4
Unit: Days
Value type: Mean
Uncertainty type: Range
Uncertainty lower value: 0
Uncertainty upper value: 13
Combined uncertainty: 0 - 13 (Range)
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 6
Unit: Days
Value type: Mean
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Contact based
Sex: Both
Sample size: 3
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Household contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Contact based
Sex: Both
Minimum age: 0
Maximum age: 82
Sample size: 212
Country: Vietnam
Location: national
Study period: 26 Feb-02 2003 to 28 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 10.1
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 22
CFR/IFR denominator: 218
CFR/IFR method: Adjusted
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 218
Country: Hong Kong SAR,  China
Location: Princess Margaret Hospital
Study period: 26 Feb-02 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 218
Country: Hong Kong SAR,  China
Location: Princess Margaret Hospital
Study period: 26 Feb-02 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Cormobidity;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 218
Country: Hong Kong SAR,  China
Location: Princess Margaret Hospital
Study period: 26 Feb-02 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 4.4
Unit: Days
Value type: Mean
Uncertainty single value: 2.3 (Standard Deviation)
Combined uncertainty: 2.3 (Standard Deviation)
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 218
Country: Hong Kong SAR,  China
Location: Princess Margaret Hospital
Study period: 26 Feb-02 2003 to 31 Mar-03 2003
Other delay start: Symptom Onset/Fever
Other delay end: Other: Sample collection
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 85.1
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 74
CFR/IFR denominator: 87
Epidemic phase: Mid outbreak
Population group: Other
Sample type: Hospital based
Sex: Both
Sample size: 87
Country: Hong Kong SAR,  China
Location: Princess Margaret Hospital
Study period: 26 Feb-02 2003 to 31 Mar-03 2003